Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06205719

Effect of Remazolam on Anesthesia Recovery in Patients Undergoing Fundus Surgery

Effect of Remazolam on Anesthesia Recovery in Patients Undergoing Fundus Surgery-A Single-center, Prospective, Randomized, Double-blind, Controlled Clinical Trial

Status
Not Yet Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
93 (estimated)
Sponsor
Sichuan Provincial People's Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

to investigate the effect of remazolam benzenesulfonate in patients with ocular fundus surgery, so as to guide clinical anesthesiologists to choose more appropriate anesthetic drugs in fundus surgery

Detailed description

to investigate the effect of remazolam benzenesulfonate in patients with ocular fundus surgery, so as to guide clinical anesthesiologists to choose more appropriate anesthetic drugs in fundus surgery。There are three groups.In Group H, ciprofol + Remifentanil was used for maintenance of anesthesia, in Group R, remifentanil + Remifentanil was used for maintenance of anesthesia, in Group RF, remifentanil + Remifentanil was used for maintenance of anesthesia, at the end of the operation, flumazenil was used to counteract the residual anesthetic effect.The quality of postoperative recovery was compared

Conditions

Interventions

TypeNameDescription
DRUGciprofolsedation
DRUGRemazolamsedation
DRUGFlumazenilantagonism
DRUGRemifentanil2ug/kg Remifentanil

Timeline

Start date
2024-06-01
Primary completion
2025-05-30
Completion
2026-05-30
First posted
2024-01-16
Last updated
2024-05-20

Source: ClinicalTrials.gov record NCT06205719. Inclusion in this directory is not an endorsement.